Cellebrite DI Ltd. Provides Revenue Guidance for the Second Quarter and Second Half of 2022
For the second half, the company expects revenue to be higher than first half revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.34 USD | -2.86% | -5.36% | +20.32% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
1st Jan change | Capi. | |
---|---|---|
+20.32% | 2.19B | |
+9.06% | 3,085B | |
+7.11% | 85.92B | |
+3.68% | 77.91B | |
-16.81% | 52.89B | |
+22.68% | 48.28B | |
+27.96% | 45.38B | |
-33.72% | 40.83B | |
+69.75% | 38.78B | |
+0.16% | 27.48B |